← Leaderboards
Shi-Hua Xiang
University Of Nebraska Lincoln
$920,697
Attributed
$920,697
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $260.6K · FY2017–22$500K$375K$250K$125K$0
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$920,697 · 2
By mechanism
R21$920,697 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Nebraska Lincoln
Same institution · by research overlap
- Hendrik J Viljoen$2,945,184
- Jeffrey D. Cirillo$7,705,565
Others in their field
Other Emerging Leaders on “Cessation Of Life”
- Xinhua Li · Nano Terra, Inc.$32,520,955
- Christopher Barnaby Nelson · University Of Melbourne$27,954,628
- Abraham Aizer Brody · New York University School Of Medicine$21,799,826
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$20,810,724
- Jeffrey Reich · Sparian Biosciences, Inc.$20,633,040
- Beth Baseler · Leidos Biomedical Research, Inc.$18,109,529
Research focus
Cessation Of LifeGlycoproteinsMortalityVirus DiseasesCellsBaseEbola VirusInfectionPharmaceutical PreparationsViral Hemorrhagic FeversViralBindingAfricaMouse ModelAffectDisease OutbreaksFight AgainstCollegeBinding SitesDesignClinical TrialsEfficacy TestingDangerousnessCytoplasm
Grant awards (4)
Structure-Based Design of Peptide Entry Inhibitors against Ebola Virus Infection$209,109
R21 · FY2022 · AI · contact PI
Structure-Based Design of Peptide Entry Inhibitors against Ebola Virus Infection$259,074
R21 · FY2021 · AI · contact PI
Mucosal Delivery and Retention of Ebola Inhibitor Scytovirin Using Lactobacillus$260,639
R21 · FY2018 · AI · contact PI
Mucosal Delivery and Retention of Ebola Inhibitor Scytovirin Using Lactobacillus$191,875
R21 · FY2017 · AI · contact PI